It analyzes their mechanisms of action in detail and discusses therapeutic strategies targeting SIRT3, SIRT6 and SIRT7 and their related molecular pathways, providing useful clues for the future search for new IPF treatment targets and the development of new therapies. This evidence concerns the gene SIRT6 and idiopathic pulmonary fibrosis.